Clinical trial
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
NCT06260891 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 14, 2026
- Completion date
- December 31, 2027
- Enrollment
- 34 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease